department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

BIOCRYST PHARMACEUTICALS INC ($BCRX) · pharmadog

PUBLIC COMPANY

$BCRXBIOCRYST PHARMACEUTICALS INC

Durham, NC, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

6

marketed

2

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(6)

pipeline depth6 products

1Phase 11Phase 21Phase 32Marketed1Unknown

berotralstat hydrochloride

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…

Influenzavirus A Infections

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…

Netherton Syndrome (Bamboo Hair)

Atopic Dermatitis (Atopic Eczema)

1 INDICATIONS AND USAGE ORLADEYO ® is indicated for proph…

Plasma kallikrein

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view BIOCRYST PHARMACEUTICALS INC jobs →

News

no news has mentioned this company yet

identifiers

ticker

$BCRX

SEC CIK

0000882796

country

US

source

sec_tickers

top tags

Dermatology2 Immunology2 Infectious Disease1

mentioned in

0news items

entity-linker matched

$BCRX

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR · openFDA

last refreshed 32m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase1A Study of Avoralstat In Participants With Diabetic Macular Edemaactive not recruitingn=9
phase1A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725recruitingn=78
phase3Berotralstat Treatment in Children With Hereditary Angioedemaactive not recruitingn=29
phase3Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studiesenrolling by invitationn=139
phase312-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attackscompletedn=110
phase2Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuriaterminatedn=28
phase2A Long-Term Safety Study of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)terminatedn=19
phase2BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapyterminatedn=12

more trials →

Insider activity

source: SEC Form 4

open-market buys + sells

Mar 20, 26SELLHEGGIE THERESA· director49,933 sh @ $10.11−$505K↗
Mar 16, 26SELLBarnes Alane P· Chief Legal Officer150,000 sh @ $9.15−$1.37M↗

routine RSU / option mechanics (6)

Apr 6, 26grantMenon Sandeep · Chief R&D Officer441,350 sh
Apr 6, 26grantMenon Sandeep · Chief R&D Officer205,150 sh
Mar 20, 26option exerciseHEGGIE THERESA · director49,933 sh
Mar 20, 26option exerciseHEGGIE THERESA · director49,933 sh
Mar 16, 26option exerciseBarnes Alane P · Chief Legal Officer150,000 sh
Mar 16, 26option exerciseBarnes Alane P · Chief Legal Officer150,000 sh